The biological crosstalk between metabolic syndrome and multiple myeloma (MM) involves multi-dimensional molecular interactions: obesity-induced bone marrow adipocytes (BMAs) secrete adipokines such as adiponectin. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.